Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 01 1997, 19-22, Vol 4, No. 1
MC Yang, DM Magee, L Kaufman, Y Zhu and RA Cox
We undertook an investigation to assess the utility of a recombinant
Coccidioides immitis complement-fixing (CF) antigen for detecting CF
antibody in sera from patients with coccidioidomycosis. Enzyme-linked
immunosorbent assays established that recombinant CF antigen and, for
comparison, a commercially available coccidioidin were reactive with 19 of
19 sera from patients with active coccidioidomycosis. The recombinant
antigen was significantly more sensitive than coccidioidin. The median
titer obtained when patients' sera were assayed against recombinant CF
antigen was 1:51,200 compared to 1:25,600 with coccidioidin (P < 0.027).
The recombinant antigen was also more effective in distinguishing the
antibody levels in sera from patients with pulmonary coccidioidomycosis
than in sera from those with disseminated disease. Whereas patients with
pulmonary disease showed a median antibody titer of 1:25,600, those with
multifocal disease showed a median titer of 1:102,400 (P < 0.028). The
recombinant CF antigen was found, however, to express an epitope(s) that
reacted with sera from 6 of 12 patients with histoplasmosis and 2 of 12
patients with blastomycosis.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Recombinant Coccidioides immitis complement-fixing antigen: detection of an epitope shared by C. immitis, Histoplasma capsulatum, and Blastomyces dermatitidis
Department of Clinical Investigation, Texas Center for Infectious Disease, San Antonio 78223, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»